View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Vital Energy Announces Early Results and Increase of its Cash Tender O...

Vital Energy Announces Early Results and Increase of its Cash Tender Offers for its Senior Notes due 2028 and Senior Notes due 2030; Planned Redemption of Senior Notes due 2028 TULSA, OK, March 28, 2024 (GLOBE NEWSWIRE) -- Vital Energy, Inc., a Delaware corporation (NYSE: VTLE) (“Vital Energy” or the “Company”) today announced the early results of its previously announced cash tender offers (the “Tender Offers”) to purchase for cash up to $550.0 million aggregate principal amount (as such aggregate principal amount may be increased or decreased by the Company, the “Aggregate Maximum Tende...

Devon Energy Corporation: Diversified and resilient asset base with st...

Our credit view of this issuer reflects its capital allocation flexibility, offset by its share repurchases.

 PRESS RELEASE

Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Dir...

Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering CHATHAM, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical company, today announced it has entered into a securities purchase agreement with existing healthcare focused institutional investors of the Company for the purchase and sale of 14,666,666 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to an aggregate of 14,666,666 shares of common stock in a registered dire...

 PRESS RELEASE

FibroBiologics Files Patent Application Covering Fibroblast-based Tech...

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus HOUSTON, March 28, 2024 (GLOBE NEWSWIRE) -- FibroBiologics (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced the filing of a patent application with the United States Patent Office covering the use of FibroBiologics’ fibroblast cell-based technology for the potential t...

 PRESS RELEASE

Verizon Joins RE100 and Shares New Milestones in its Responsible Busin...

Verizon Joins RE100 and Shares New Milestones in its Responsible Business Plan NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Today, Verizon announced it has joined RE100, a global initiative bringing together the world’s most influential businesses committed to 100% renewable electricity. Led by the Climate Group and in partnership with CDP, RE100’s mission is to accelerate change towards zero carbon grids at scale, an objective that Verizon is proud to support. As previously announced, Verizon aims to source renewable energy equivalent to 100% of its annual electricity usage by 2030, with...

 PRESS RELEASE

Coinsilium Group Limited: Total Voting Rights

Coinsilium Group Limited (COIN) Coinsilium Group Limited: Total Voting Rights 28-March-2024 / 13:19 GMT/BST COINSILIUM GROUP LIMITED("Coinsilium" or the "Company")Total Voting Rights  London, UK, 28 March 2024 - In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, Coinsilium hereby announces that it has 217,464,234  ordinary shares of nil par value ("Ordinary Shares") in issue, each share carrying the right to one vote. The Company does not hold any Ordinary Shares in treasury. The figure of 217,464,234 Ordinary Shares may be used by shareholders in...

INW Manufacturing, LLC: Update to credit analysis following upgrade to...

Our credit view of this issuer reflects its participation in the growing vitamins, minerals and supplement industry.

 PRESS RELEASE

Vaxxinity to Present Clinical Data at the Annual Academy of Neurology ...

Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting Presentation will address the Company’s clinical data in Parkinson’s disease CAPE CANAVERAL, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: ), a U.S. company pioneering the development of a new class of medicines, today announced it will present clinical data from its UB-312 program in Parkinson’s disease at the , taking place April 13-18, 2024 virtually and in Denver, Colorado. Presentation details are as follows:Oral PresentationSession: ES2 - Emerging ScienceTitle: Presen...

 PRESS RELEASE

Alliance Trust PLC - Net Asset Value

Alliance Trust PLC - Net Asset Value ALLIANCE TRUST PLC                 At the close of business Wednesday 27 March 2024: The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 1285.2p                 -       including income, 1287.8p   The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding income, 1288.4p -       including income, 1291.0p For further information, please contact: -  Juniper Partners LimitedTel. +44 (0)131 378 0500 Notes Net Asset Values are calculated ...

Merck & Co., Inc. - December 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Amira Manai
  • Amira Manai

HighCo : Record 2023 results - Caution on 2024 due to risks associated...

>Adjusted earnings on ordinary activities of € 16.4m, i.e. an operating margin of 22.1% (+150bp) - Yesterday evening, HighCo reported record earnings for 2023. Despite a gross margin (already published) down 2.7% to € 74.4m, adjusted earnings on ordinary activities came in at € 16.4m, revealing a 150bp improvement to the operating margin to 22.1%, in line with the guidance announced in January and with our forecast (22.1%). This operational performance stems from eff...

NCL Corporation Ltd. - December 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Ithaca Energy plc: Potential transformational combination with Eni's U...

The transaction would enlarge Ithaca's scale and boost its cash-flow generation capacity.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch